| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 6.04e-05 | 4 | 64 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.68e-04 | 279 | 64 | 6 | GO:0005096 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 2.80e-04 | 8 | 64 | 2 | GO:0098882 | |
| GeneOntologyBiologicalProcess | synapse organization | EPHB3 DIP2A DRP2 ABI3BP NRXN2 PCLO NBEA BSN DCLK1 NRP2 NEDD4 SYNGAP1 | 1.56e-06 | 685 | 66 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 DIP2A DRP2 ABI3BP NRXN2 HIPK1 PCLO NBEA BSN DCLK1 NRP2 NEDD4 SYNGAP1 | 1.07e-05 | 974 | 66 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 3.02e-05 | 3 | 66 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 3.67e-05 | 395 | 66 | 8 | GO:0050803 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB3 DIP2A NKX2-8 ABI3BP NCAM1 MUC3A DCLK1 NRP2 NEDD4 SOS1 SYNGAP1 | 5.70e-05 | 826 | 66 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 6.03e-05 | 4 | 66 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 6.27e-05 | 313 | 66 | 7 | GO:0099173 | |
| GeneOntologyBiologicalProcess | cranial nerve development | 6.30e-05 | 67 | 66 | 4 | GO:0021545 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 1.00e-04 | 5 | 66 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 DIP2A NKX2-8 ABI3BP NCAM1 DCLK1 NRP2 NEDD4 SOS1 SYNGAP1 | 1.24e-04 | 748 | 66 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 1.50e-04 | 6 | 66 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | vestibulocochlear nerve morphogenesis | 2.10e-04 | 7 | 66 | 2 | GO:0021648 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB3 DIP2A NKX2-8 ABI3BP NCAM1 DCLK1 NRP2 NEDD4 SOS1 SYNGAP1 | 2.19e-04 | 802 | 66 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 2.33e-04 | 387 | 66 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB3 DIP2A NKX2-8 ABI3BP NCAM1 DCLK1 NRP2 NEDD4 SOS1 SYNGAP1 | 2.59e-04 | 819 | 66 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 2.84e-04 | 40 | 66 | 3 | GO:0099558 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 DIP2A NKX2-8 ABI3BP FRMD6 NCAM1 MUC3A DCLK1 NRP2 NEDD4 SOS1 SYNGAP1 | 3.60e-04 | 1194 | 66 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | nerve development | 4.13e-04 | 109 | 66 | 4 | GO:0021675 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 4.13e-04 | 109 | 66 | 4 | GO:0090630 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 4.31e-04 | 198 | 66 | 5 | GO:0048813 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 4.46e-04 | 10 | 66 | 2 | GO:1990709 | |
| GeneOntologyBiologicalProcess | synapse assembly | 4.52e-04 | 308 | 66 | 6 | GO:0007416 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 5.06e-04 | 115 | 66 | 4 | GO:0035418 | |
| GeneOntologyBiologicalProcess | vestibulocochlear nerve development | 5.44e-04 | 11 | 66 | 2 | GO:0021562 | |
| GeneOntologyBiologicalProcess | learned vocalization behavior or vocal learning | 5.44e-04 | 11 | 66 | 2 | GO:0098598 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 DIP2A NKX2-8 NEUROG1 ABI3BP NCKIPSD NCAM1 DCLK1 NRP2 NEDD4 SOS1 SYNGAP1 | 6.96e-04 | 1285 | 66 | 12 | GO:0031175 |
| GeneOntologyBiologicalProcess | dendrite development | 7.03e-04 | 335 | 66 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 7.03e-04 | 335 | 66 | 6 | GO:0043087 | |
| GeneOntologyBiologicalProcess | trigeminal nerve development | 7.69e-04 | 13 | 66 | 2 | GO:0021559 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 8.51e-04 | 58 | 66 | 3 | GO:0097106 | |
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 DIP2A DRP2 NRXN2 PCLO SCN8A NCAM1 NBEA BSN DCLK1 NRP2 NEDD4 SYNGAP1 | 1.36e-06 | 817 | 66 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | DIP2A DRP2 ABI3BP PCLO SCN8A NCAM1 NBEA BSN CHRM5 DCLK1 NRP2 NEDD4 SYNGAP1 | 1.48e-05 | 1018 | 66 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB3 DIP2A NEUROG1 DRP2 ABI3BP PCLO SCN8A NCAM1 LMTK3 BSN CHRM5 NEDD4 SOS1 SYNGAP1 | 2.36e-05 | 1228 | 66 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | EPHB3 DIP2A DRP2 ABI3BP PCLO SCN8A LMTK3 BSN CHRM5 NEDD4 SYNGAP1 | 7.11e-05 | 858 | 66 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB3 DIP2A DRP2 ABI3BP PCLO SCN8A LMTK3 BSN CHRM5 NEDD4 SYNGAP1 | 7.26e-05 | 860 | 66 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 2.72e-04 | 8 | 66 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.93e-04 | 109 | 66 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.40e-04 | 451 | 66 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.51e-04 | 477 | 66 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 8.72e-04 | 14 | 66 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.02e-03 | 503 | 66 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.03e-03 | 141 | 66 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.28e-03 | 523 | 66 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.38e-03 | 583 | 66 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.38e-03 | 23 | 66 | 2 | GO:0098831 | |
| MousePheno | abnormal synaptic vesicle number | 2.31e-05 | 42 | 56 | 4 | MP:0004792 | |
| MousePheno | abnormal synaptic vesicle morphology | 5.02e-05 | 51 | 56 | 4 | MP:0004769 | |
| MousePheno | abnormal mouth morphology | DIP2A ABI3BP MAP3K11 NBEA TWSG1 EYA1 AGAP7P AGAP4 AGAP6 NEDD4 SOS1 | 5.85e-05 | 670 | 56 | 11 | MP:0000452 |
| MousePheno | abnormal accessory nerve morphology | 9.41e-05 | 4 | 56 | 2 | MP:0001075 | |
| MousePheno | abnormal head morphology | DIP2A ABI3BP MAP3K11 NBEA TWSG1 EYA1 HUWE1 AGAP7P AGAP4 AGAP6 SON NRP2 NEDD4 SOS1 | 9.84e-05 | 1120 | 56 | 14 | MP:0000432 |
| MousePheno | abnormal viscerocranium morphology | DIP2A ABI3BP MAP3K11 TWSG1 EYA1 AGAP7P AGAP4 AGAP6 NEDD4 SOS1 | 1.07e-04 | 593 | 56 | 10 | MP:0005274 |
| MousePheno | fused cornea and lens | 1.16e-04 | 24 | 56 | 3 | MP:0001307 | |
| MousePheno | abnormal thyroid gland isthmus morphology | 1.56e-04 | 5 | 56 | 2 | MP:0013162 | |
| MousePheno | myoclonus | 2.07e-04 | 29 | 56 | 3 | MP:0000243 | |
| MousePheno | abnormal facial morphology | DIP2A ABI3BP MAP3K11 NBEA TWSG1 EYA1 AGAP7P AGAP4 AGAP6 NRP2 NEDD4 SOS1 | 2.09e-04 | 910 | 56 | 12 | MP:0003743 |
| MousePheno | abnormal jaw morphology | 2.34e-04 | 530 | 56 | 9 | MP:0000454 | |
| MousePheno | abnormal glossopharyngeal ganglion morphology | 2.78e-04 | 32 | 56 | 3 | MP:0001096 | |
| MousePheno | abnormal muscle physiology | ARHGAP42 PPP1R3A ABI3BP TULP4 SPEG SCN8A NBEA CMYA5 BSN CHRM5 NRP2 SOS1 | 3.23e-04 | 954 | 56 | 12 | MP:0002106 |
| Domain | PH_dom-like | ARHGAP42 FRMD6 NBEA AGAP7P PLEKHH2 AGAP4 AGAP6 FRMD4B SOS1 SYNGAP1 | 2.31e-06 | 426 | 66 | 10 | IPR011993 |
| Domain | Znf_piccolo | 1.23e-05 | 2 | 66 | 2 | IPR008899 | |
| Domain | zf-piccolo | 1.23e-05 | 2 | 66 | 2 | PF05715 | |
| Domain | PH | 5.52e-05 | 278 | 66 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 5.65e-05 | 279 | 66 | 7 | PS50003 | |
| Domain | PH_domain | 5.78e-05 | 280 | 66 | 7 | IPR001849 | |
| Domain | - | 6.83e-05 | 391 | 66 | 8 | 2.30.29.30 | |
| Domain | SEA | 7.10e-05 | 23 | 66 | 3 | PS50024 | |
| Domain | SEA_dom | 7.10e-05 | 23 | 66 | 3 | IPR000082 | |
| Domain | DMAP_binding | 1.22e-04 | 5 | 66 | 2 | PF06464 | |
| Domain | ArfGap | 1.44e-04 | 29 | 66 | 3 | SM00105 | |
| Domain | ArfGap | 1.44e-04 | 29 | 66 | 3 | PF01412 | |
| Domain | ARFGAP | 1.44e-04 | 29 | 66 | 3 | PS50115 | |
| Domain | ArfGAP | 1.44e-04 | 29 | 66 | 3 | IPR001164 | |
| Domain | PH | 1.56e-04 | 229 | 66 | 6 | PF00169 | |
| Domain | DMAP1-bd | 1.83e-04 | 6 | 66 | 2 | IPR010506 | |
| Domain | DMAP_binding | 1.83e-04 | 6 | 66 | 2 | SM01137 | |
| Domain | fn3 | 2.69e-04 | 162 | 66 | 5 | PF00041 | |
| Domain | FN3 | 4.95e-04 | 185 | 66 | 5 | SM00060 | |
| Domain | FERM_M | 5.74e-04 | 46 | 66 | 3 | PF00373 | |
| Domain | FN3 | 6.89e-04 | 199 | 66 | 5 | PS50853 | |
| Domain | - | 6.91e-04 | 49 | 66 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 6.91e-04 | 49 | 66 | 3 | IPR019748 | |
| Domain | FERM_domain | 6.91e-04 | 49 | 66 | 3 | IPR000299 | |
| Domain | FERM_1 | 7.34e-04 | 50 | 66 | 3 | PS00660 | |
| Domain | FERM_2 | 7.34e-04 | 50 | 66 | 3 | PS00661 | |
| Domain | FERM_3 | 7.34e-04 | 50 | 66 | 3 | PS50057 | |
| Domain | Band_41_domain | 7.34e-04 | 50 | 66 | 3 | IPR019749 | |
| Domain | B41 | 7.34e-04 | 50 | 66 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 7.34e-04 | 50 | 66 | 3 | IPR014352 | |
| Domain | FN3_dom | 8.59e-04 | 209 | 66 | 5 | IPR003961 | |
| Domain | SEA | 1.09e-03 | 14 | 66 | 2 | SM00200 | |
| Domain | SEA | 2.71e-03 | 22 | 66 | 2 | PF01390 | |
| Domain | SAM | 3.73e-03 | 88 | 66 | 3 | SM00454 | |
| Domain | FERM_C | 3.78e-03 | 26 | 66 | 2 | PF09380 | |
| Domain | RASGEF | 3.78e-03 | 26 | 66 | 2 | PS00720 | |
| Domain | HECT | 4.08e-03 | 27 | 66 | 2 | PF00632 | |
| Domain | HECTc | 4.08e-03 | 27 | 66 | 2 | SM00119 | |
| Domain | HECT_dom | 4.08e-03 | 27 | 66 | 2 | IPR000569 | |
| Domain | FERM_C | 4.08e-03 | 27 | 66 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 4.08e-03 | 27 | 66 | 2 | IPR018980 | |
| Domain | HECT | 4.08e-03 | 27 | 66 | 2 | PS50237 | |
| Domain | SAM_DOMAIN | 4.63e-03 | 95 | 66 | 3 | PS50105 | |
| Domain | RASGEF_CAT | 4.70e-03 | 29 | 66 | 2 | PS50009 | |
| Domain | SAM | 4.90e-03 | 97 | 66 | 3 | IPR001660 | |
| Domain | AMP-binding | 5.02e-03 | 30 | 66 | 2 | PF00501 | |
| Domain | RasGEF | 5.02e-03 | 30 | 66 | 2 | PF00617 | |
| Domain | - | 5.02e-03 | 30 | 66 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 5.02e-03 | 30 | 66 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 5.02e-03 | 30 | 66 | 2 | IPR001895 | |
| Domain | AMP-dep_Synth/Lig | 5.02e-03 | 30 | 66 | 2 | IPR000873 | |
| Domain | UBA | 5.02e-03 | 30 | 66 | 2 | SM00165 | |
| Domain | RasGEF | 5.02e-03 | 30 | 66 | 2 | SM00147 | |
| Domain | PROTEIN_KINASE_ATP | 5.58e-03 | 459 | 66 | 6 | PS00107 | |
| Domain | FERM_N | 6.05e-03 | 33 | 66 | 2 | PF09379 | |
| Domain | FERM_N | 6.05e-03 | 33 | 66 | 2 | IPR018979 | |
| Domain | - | 6.27e-03 | 106 | 66 | 3 | 1.10.150.50 | |
| Domain | MAGE | 6.41e-03 | 34 | 66 | 2 | SM01373 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.21e-07 | 16 | 42 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.57e-07 | 17 | 42 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.78e-07 | 23 | 42 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 9.70e-07 | 26 | 42 | 4 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.35e-05 | 62 | 42 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.83e-05 | 68 | 42 | 4 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.24e-04 | 111 | 42 | 4 | M27416 | |
| Pubmed | 1.10e-09 | 347 | 66 | 10 | 17114649 | ||
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 2.46e-09 | 10 | 66 | 4 | 20664521 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.19e-09 | 281 | 66 | 9 | 28706196 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 8.56e-09 | 430 | 66 | 10 | 35044719 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.55e-08 | 18 | 66 | 4 | 18834073 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.91e-07 | 231 | 66 | 7 | 16452087 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 5.44e-07 | 9 | 66 | 3 | 12640130 | |
| Pubmed | 6.91e-07 | 87 | 66 | 5 | 12465718 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.07e-06 | 11 | 66 | 3 | 15381706 | |
| Pubmed | 1.45e-06 | 101 | 66 | 5 | 10997877 | ||
| Pubmed | 1.84e-06 | 13 | 66 | 3 | 27713690 | ||
| Pubmed | UBAP2L NCAM1 NBEA HUWE1 LMTK3 BSN DCLK1 NUP153 LRRC15 NEDD4 SYNGAP1 | 1.85e-06 | 963 | 66 | 11 | 28671696 | |
| Pubmed | 2.34e-06 | 14 | 66 | 3 | 22453919 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 35533267 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 3.55e-06 | 2 | 66 | 2 | 23403927 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12137943 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 3.55e-06 | 2 | 66 | 2 | 26793095 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 20332206 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 3.55e-06 | 2 | 66 | 2 | 21935939 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 23544943 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19213029 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27321892 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 32493491 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 3.55e-06 | 2 | 66 | 2 | 25652077 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 3.76e-06 | 218 | 66 | 6 | 33378226 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP3 DIP2A TULP4 SPEG SCN8A DIP2C MAP3K11 CEP192 HUWE1 ELL PHC2 | 6.87e-06 | 1105 | 66 | 11 | 35748872 |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 23053434 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 30236127 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 1.06e-05 | 3 | 66 | 2 | 17592322 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 26770020 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 17236128 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 15580621 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 35879412 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 27483328 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 24204560 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 24939955 | ||
| Pubmed | Von Hippel-Lindau Acts as a Metabolic Switch Controlling Nephron Progenitor Differentiation. | 1.28e-05 | 24 | 66 | 3 | 31142573 | |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 1.68e-05 | 80 | 66 | 4 | 19389623 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 27184401 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 14637006 | ||
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 2.12e-05 | 4 | 66 | 2 | 39024979 | |
| Pubmed | Two Nedd4-binding motifs underlie modulation of sodium channel Nav1.6 by p38 MAPK. | 2.12e-05 | 4 | 66 | 2 | 20530479 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 25752299 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 28425671 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 27159043 | ||
| Pubmed | Expression of bHLH transcription factors NSCL1 and NSCL2 in the mouse olfactory system. | 3.53e-05 | 5 | 66 | 2 | 14578122 | |
| Pubmed | 4.84e-05 | 37 | 66 | 3 | 16319116 | ||
| Pubmed | An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan. | 5.29e-05 | 6 | 66 | 2 | 19482073 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 19812333 | ||
| Pubmed | β-Sheet Augmentation Is a Conserved Mechanism of Priming HECT E3 Ligases for Ubiquitin Ligation. | 5.29e-05 | 6 | 66 | 2 | 29964046 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 14734538 | ||
| Pubmed | 6.49e-05 | 529 | 66 | 7 | 14621295 | ||
| Pubmed | DIP2A NRXN2 UBAP2L PCLO SYNGR3 NCKIPSD NCAM1 NBEA BSN DCLK1 SYNGAP1 | 7.38e-05 | 1431 | 66 | 11 | 37142655 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 15817220 | ||
| Pubmed | 7.46e-05 | 117 | 66 | 4 | 17145500 | ||
| Pubmed | 8.75e-05 | 45 | 66 | 3 | 19877281 | ||
| Pubmed | SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1. | 9.86e-05 | 8 | 66 | 2 | 9346925 | |
| Pubmed | Widespread defects in the primary olfactory pathway caused by loss of Mash1 function. | 9.86e-05 | 8 | 66 | 2 | 12629181 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.07e-04 | 774 | 66 | 8 | 15302935 | |
| Pubmed | 1.16e-04 | 131 | 66 | 4 | 28634551 | ||
| Pubmed | 1.17e-04 | 251 | 66 | 5 | 27507650 | ||
| Pubmed | 1.24e-04 | 407 | 66 | 6 | 12693553 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 21356198 | ||
| Pubmed | The role of Eya1 and Eya2 in the taste system of mice from embryonic stage to adulthood. | 1.27e-04 | 9 | 66 | 2 | 37181748 | |
| Pubmed | Six1 is required for the early organogenesis of mammalian kidney. | 1.27e-04 | 9 | 66 | 2 | 12783782 | |
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 11782456 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 15716344 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 21144999 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 22513373 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 9707552 | ||
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 1.43e-04 | 53 | 66 | 3 | 15572359 | |
| Pubmed | DIP2A HIPK1 MAP3K11 NBEA HUWE1 CMYA5 FRMD4B DCLK1 SOS1 SYNGAP1 | 1.47e-04 | 1285 | 66 | 10 | 35914814 | |
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 10781944 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 30718617 | ||
| Pubmed | Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme. | 1.58e-04 | 10 | 66 | 2 | 16442091 | |
| Pubmed | Foxg1 promotes olfactory neurogenesis by antagonizing Gdf11. | 1.58e-04 | 10 | 66 | 2 | 19297409 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 22171039 | ||
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 15604101 | ||
| Pubmed | Mouse Hoxa2 mutations provide a model for microtia and auricle duplication. | 1.93e-04 | 11 | 66 | 2 | 24067355 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 25315821 | ||
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 16916509 | ||
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 21852401 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 28700933 | ||
| Pubmed | Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. | 2.31e-04 | 12 | 66 | 2 | 11688560 | |
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 16193510 | ||
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 2.31e-04 | 12 | 66 | 2 | 21465626 | |
| Pubmed | Multiple roles of integrin-α3 at the neuromuscular junction. | 2.31e-04 | 12 | 66 | 2 | 28386022 | |
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 25007825 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 20736290 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 28407732 | ||
| Pubmed | Dicer function is required in the metanephric mesenchyme for early kidney development. | 2.31e-04 | 12 | 66 | 2 | 24500693 | |
| Pubmed | Secreted TARSH regulates olfactory mitral cell dendritic complexity. | 2.31e-04 | 12 | 66 | 2 | 19302145 | |
| Pubmed | 2.68e-04 | 300 | 66 | 5 | 19086053 | ||
| Pubmed | Maturation of the olfactory sensory neurons by Apaf-1/caspase-9-mediated caspase activity. | 2.73e-04 | 13 | 66 | 2 | 20624980 | |
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 16267092 | ||
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 38692273 | ||
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 18024993 | ||
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 15123669 | ||
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 25219788 | ||
| Pubmed | Eya1 and Six1 are essential for early steps of sensory neurogenesis in mammalian cranial placodes. | 2.73e-04 | 13 | 66 | 2 | 15496442 | |
| Cytoband | 13q13 | 2.03e-05 | 5 | 66 | 2 | 13q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 1.61e-04 | 188 | 66 | 4 | chr10q11 | |
| Cytoband | Xq26 | 1.83e-04 | 14 | 66 | 2 | Xq26 | |
| Cytoband | 10q11.23 | 1.04e-03 | 33 | 66 | 2 | 10q11.23 | |
| Cytoband | 7q22 | 1.38e-03 | 38 | 66 | 2 | 7q22 | |
| Cytoband | 2p21 | 3.53e-03 | 61 | 66 | 2 | 2p21 | |
| GeneFamily | CD molecules|Mucins | 2.53e-07 | 21 | 48 | 4 | 648 | |
| GeneFamily | ArfGAPs | 9.06e-05 | 33 | 48 | 3 | 395 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.15e-04 | 181 | 48 | 5 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.10e-04 | 206 | 48 | 5 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.15e-04 | 50 | 48 | 3 | 1293 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 7.09e-04 | 15 | 48 | 2 | 26 | |
| GeneFamily | Fibronectin type III domain containing | 8.49e-04 | 160 | 48 | 4 | 555 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 9.15e-04 | 17 | 48 | 2 | 1291 | |
| GeneFamily | Sterile alpha motif domain containing | 1.65e-03 | 88 | 48 | 3 | 760 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.68e-03 | 29 | 48 | 2 | 396 | |
| GeneFamily | MAGE family | 5.05e-03 | 40 | 48 | 2 | 1136 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | HIVEP3 TULP4 NRXN2 SPEG PCLO SYNGR3 SCN8A NCAM1 NBEA BSN CHRM5 FRMD4B DCLK1 NRP2 | 5.20e-07 | 1106 | 66 | 14 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 2.44e-06 | 465 | 66 | 9 | M39066 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | 9.84e-06 | 703 | 66 | 10 | M39070 | |
| Coexpression | GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN | 1.14e-05 | 200 | 66 | 6 | M8052 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 1.52e-05 | 584 | 66 | 9 | M39068 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB3 SSC5D DIP2A SALL1 TULP4 NRXN2 PCLO NCAM1 NBEA TWSG1 LMTK3 | 1.09e-05 | 722 | 65 | 11 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_200 | 2.25e-05 | 54 | 65 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 7.19e-05 | 732 | 65 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ARHGAP42 DRP2 ABI3BP MUC16 NCAM1 CEP192 EYA1 PLEKHH2 FRMD4B DCLK1 | 1.18e-04 | 777 | 65 | 10 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 1.28e-04 | 84 | 65 | 4 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ARHGAP42 DRP2 MUC16 NCAM1 CEP192 EYA1 PLEKHH2 FRMD4B DCLK1 SYNGAP1 | 1.39e-04 | 793 | 65 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | ARHGAP42 DRP2 ABI3BP FRMD6 MUC16 NCAM1 PLEKHH2 FRMD4B DCLK1 SYNGAP1 | 1.45e-04 | 797 | 65 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.69e-04 | 658 | 65 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.23e-04 | 683 | 65 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.24e-04 | 97 | 65 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#1 | 2.92e-04 | 104 | 65 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 3.66e-04 | 436 | 65 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 4.03e-04 | 740 | 65 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 4.03e-04 | 47 | 65 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.15e-04 | 743 | 65 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.31e-04 | 747 | 65 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-07 | 182 | 66 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-07 | 182 | 66 | 6 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-07 | 182 | 66 | 6 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.86e-07 | 190 | 66 | 6 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-07 | 190 | 66 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.10e-07 | 192 | 66 | 6 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.10e-07 | 192 | 66 | 6 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-06 | 161 | 66 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.39e-06 | 170 | 66 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.86e-06 | 173 | 66 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.73e-06 | 178 | 66 | 5 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-06 | 178 | 66 | 5 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-06 | 178 | 66 | 5 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.73e-06 | 178 | 66 | 5 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.92e-06 | 179 | 66 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-06 | 179 | 66 | 5 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.30e-06 | 181 | 66 | 5 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.50e-06 | 182 | 66 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.70e-06 | 183 | 66 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-06 | 184 | 66 | 5 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.12e-06 | 185 | 66 | 5 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.34e-06 | 186 | 66 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.55e-06 | 187 | 66 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 188 | 66 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 188 | 66 | 5 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 188 | 66 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 189 | 66 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.01e-06 | 189 | 66 | 5 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 189 | 66 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-06 | 189 | 66 | 5 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 189 | 66 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 9.24e-06 | 190 | 66 | 5 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 190 | 66 | 5 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 190 | 66 | 5 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-06 | 190 | 66 | 5 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 191 | 66 | 5 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 191 | 66 | 5 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.48e-06 | 191 | 66 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.72e-06 | 192 | 66 | 5 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.72e-06 | 192 | 66 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.72e-06 | 192 | 66 | 5 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 192 | 66 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.97e-06 | 193 | 66 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 194 | 66 | 5 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 194 | 66 | 5 | c422aeddb4e949a22f731da675bdf91dee86ba61 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 194 | 66 | 5 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 194 | 66 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | distal-Epithelial-Differentiating_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-05 | 195 | 66 | 5 | 3fe6e49a9161fc9e5160251e6932cb5378175a54 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 195 | 66 | 5 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 195 | 66 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 196 | 66 | 5 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.10e-05 | 197 | 66 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.10e-05 | 197 | 66 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 198 | 66 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 198 | 66 | 5 | cbb63b255bdc92a557c5db1f08f7766ed9346607 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 199 | 66 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 199 | 66 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 199 | 66 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 199 | 66 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 199 | 66 | 5 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-05 | 200 | 66 | 5 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.18e-05 | 200 | 66 | 5 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.18e-05 | 200 | 66 | 5 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 107 | 66 | 4 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 107 | 66 | 4 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 123 | 66 | 4 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.93e-05 | 128 | 66 | 4 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-05 | 152 | 66 | 4 | 3951a9f5fe164002311ed2ef7c36ae958451826b | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-valve_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 153 | 66 | 4 | 1440f2716fea74e2c3eb2924eba3d63ebd08c997 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.48e-05 | 156 | 66 | 4 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.91e-05 | 158 | 66 | 4 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-04 | 163 | 66 | 4 | f4fcac0af9967ec34a43c9674aa17b0aa5344cf6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 164 | 66 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.08e-04 | 166 | 66 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.15e-04 | 169 | 66 | 4 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-04 | 170 | 66 | 4 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 174 | 66 | 4 | e2243f1e48e3275753a2b3a69d06eefce69a8ded | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 174 | 66 | 4 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-04 | 174 | 66 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 174 | 66 | 4 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 175 | 66 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| Drug | cellobiitol | 3.96e-06 | 37 | 66 | 4 | CID000003871 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.21e-06 | 10 | 65 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.23e-05 | 64 | 65 | 4 | DOID:4947 (is_marker_for) | |
| Disease | creatinine measurement | 6.05e-05 | 995 | 65 | 10 | EFO_0004518 | |
| Disease | Congenital small ears | 1.02e-04 | 41 | 65 | 3 | C0152423 | |
| Disease | Schizophrenia | 1.32e-04 | 883 | 65 | 9 | C0036341 | |
| Disease | Congenital Abnormality | 2.59e-04 | 11 | 65 | 2 | C0000768 | |
| Disease | Autistic Disorder | 2.79e-04 | 261 | 65 | 5 | C0004352 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.59e-04 | 152 | 65 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cup-to-disc ratio measurement | 3.70e-04 | 430 | 65 | 6 | EFO_0006939 | |
| Disease | Bipolar Disorder | 6.38e-04 | 477 | 65 | 6 | C0005586 | |
| Disease | gout | 9.31e-04 | 196 | 65 | 4 | EFO_0004274 | |
| Disease | eye color | 1.05e-03 | 90 | 65 | 3 | EFO_0003949 | |
| Disease | Neurodevelopmental Disorders | 1.15e-03 | 93 | 65 | 3 | C1535926 | |
| Disease | pancreatic cancer (is_marker_for) | 1.46e-03 | 101 | 65 | 3 | DOID:1793 (is_marker_for) | |
| Disease | unipolar depression, irritable bowel syndrome | 1.74e-03 | 28 | 65 | 2 | EFO_0000555, EFO_0003761 | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 1.87e-03 | 29 | 65 | 2 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | Schizoaffective Disorder | 1.87e-03 | 29 | 65 | 2 | C0036337 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.88e-03 | 801 | 65 | 7 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | bowel opening frequency | 2.00e-03 | 30 | 65 | 2 | EFO_0600084 | |
| Disease | Marijuana Abuse | 2.00e-03 | 30 | 65 | 2 | C0024809 | |
| Disease | Major Depressive Disorder | 2.05e-03 | 243 | 65 | 4 | C1269683 | |
| Disease | joint hypermobility measurement | 2.41e-03 | 33 | 65 | 2 | EFO_0007905 | |
| Disease | Unipolar Depression | 2.58e-03 | 259 | 65 | 4 | C0041696 | |
| Disease | posterior thigh muscle fat infiltration measurement | 2.71e-03 | 35 | 65 | 2 | EFO_0020934 | |
| Disease | bone mineral content measurement | 2.99e-03 | 130 | 65 | 3 | EFO_0007621 | |
| Disease | hepatocyte growth factor-like protein measurement | 3.19e-03 | 38 | 65 | 2 | EFO_0008154 | |
| Disease | prostate carcinoma | 3.40e-03 | 891 | 65 | 7 | EFO_0001663 | |
| Disease | Abnormality of refraction | 3.64e-03 | 673 | 65 | 6 | HP_0000539 | |
| Disease | smoking status measurement | 3.86e-03 | 1160 | 65 | 8 | EFO_0006527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NYSDTPPTSKSTVEE | 81 | Q9GZX9 | |
| YSSSIPSTPSTSQED | 191 | Q96P64 | |
| VSSVPTSTSETPDYL | 496 | P55199 | |
| YSSSIPSTPSTSQED | 191 | Q5VW22 | |
| PVSSYAESETTDSVP | 226 | P14316 | |
| VTDSPSPEYLKSDSD | 151 | Q99743 | |
| SSPYERIAPSESTTD | 3926 | Q8WXI7 | |
| DTSTTFPTLSETPYE | 11556 | Q8WXI7 | |
| STGDTTPLPVTDTYS | 2586 | Q99102 | |
| EYPCSSEVSPSTESS | 21 | Q9BZ81 | |
| PFSEESSSPVDEYTS | 866 | O60732 | |
| ISDSSSYTFPPSDDT | 186 | P46934 | |
| LSDPSSPAASEDFTY | 196 | Q92886 | |
| DSPDSDSSLSSPYST | 941 | Q86Z02 | |
| SGEYTPPAEETSSSQ | 81 | Q96Q04 | |
| SSCSEYSPSPSLDSE | 1121 | Q9UPA5 | |
| PELNSESEDYSPSSS | 716 | O15075 | |
| ESEDYSPSSSETVRS | 721 | O15075 | |
| YSEPSESATSVPPSD | 2166 | Q9Y6V0 | |
| ETAYPSSPTSTVTES | 1461 | Q02505 | |
| SETPSETPTYEASLD | 81 | A6H8Z2 | |
| TDPTAEYSTIHSPST | 271 | Q99502 | |
| EETTTPYPTEEEATE | 611 | O60462 | |
| RSEVYDPSDPTGSDS | 826 | Q9P1Y6 | |
| RFLEDDPSDPTYTSS | 781 | P54753 | |
| YPSSDESSLETSPPD | 51 | O15522 | |
| PDSYPTTPSSTDAAT | 2741 | Q7Z6Z7 | |
| DYSSSSSEANTPSPI | 396 | Q8IVE3 | |
| SDSSEDIYLDTPSSG | 46 | Q16821 | |
| DSSLPPTDDEDFYTT | 456 | P58401 | |
| PSESSSLSDTTTYDD | 576 | Q9Y2L6 | |
| TKPRDTGPEDSYSSS | 401 | Q96NE9 | |
| SEPSADSYLTLSTAP | 581 | Q711Q0 | |
| TPDSTSASEYSVPSL | 691 | Q8N3K9 | |
| DAYTPPDTSSGSEDE | 126 | Q9Y2E4 | |
| YSSSIPSTPSTSQED | 191 | Q5VUJ5 | |
| PESSYPTTATDDALE | 1046 | Q8TEP8 | |
| SSVETYTPPDTSSAS | 126 | Q14689 | |
| YTPPDTSSASEDEGS | 131 | Q14689 | |
| EGSASPTSPDYSLDS | 106 | O75995 | |
| TPVPDSYSESMESDT | 796 | Q9NSC2 | |
| YLDSDDSSPLGSPST | 591 | Q16584 | |
| SVLEADYSETPASSP | 696 | Q13474 | |
| EDSVPSPLDTNYSTS | 956 | Q8WUY3 | |
| PDTPSYPDTTSVSST | 491 | Q8TF66 | |
| TPCLAEPDSDSYSSS | 611 | A6NI28 | |
| EPDSDSYSSSPDSTP | 616 | A6NI28 | |
| SPESETDYPVSTDTR | 1011 | Q8NFP9 | |
| LESSSSYNSETPSTP | 41 | Q5JXC2 | |
| SDTTPDLDTTPYSST | 1121 | A1L4H1 | |
| YSISDRTSISDPPES | 1196 | Q07889 | |
| TSLDTLYTSSSPSEP | 221 | Q9NZQ3 | |
| TTCSSYPSSEDEDKP | 301 | P08912 | |
| SSPSIDQVEPYSSTA | 511 | P13591 | |
| DSSESDTDSDDYAPP | 226 | Q9NRJ4 | |
| YEEPLSPISASSSTS | 746 | Q8IXK0 | |
| EPVLSDYESTPTTSA | 526 | Q14157 | |
| DDTSSENTVVPPETY | 111 | P15927 | |
| STSPFSSPITSDEEY | 816 | Q15772 | |
| SSPAYCTSSSDITEP | 816 | Q96PV0 | |
| YSSEEPGPSSKDTAS | 601 | Q5T1R4 | |
| YDTLPSDTVSLSDSD | 21 | Q9Y5U2 | |
| ESTPSTASLPSYDSV | 1936 | Q9UQD0 | |
| ETYQSPPFTETLDTS | 206 | O43761 | |
| EEPSTTSTASNYPDV | 111 | P49790 | |
| DSYSSLSPETESVNP | 36 | Q6S9Z5 | |
| PEQYTDPSSSAVSTT | 146 | A0PK05 | |
| RSPSSYSSDELSPGE | 121 | Q9UHV5 | |
| TYDVFSSPTTSDEPE | 381 | Q7Z7G0 | |
| SSPTTSDEPEISDSY | 386 | Q7Z7G0 | |
| ETPTEVYPEPSTSTT | 311 | P18583 | |
| SEPSAVPTDYSVSAS | 1221 | P18583 | |
| PGLSEESTTVYSSSP | 2851 | Q9UKN1 |